95 related articles for article (PubMed ID: 12565959)
1. 1,4-Diazepane-2-ones as novel inhibitors of LFA-1.
Wattanasin S; Albert R; Ehrhardt C; Roche D; Sabio M; Hommel U; Welzenbach K; Weitz-Schmidt G
Bioorg Med Chem Lett; 2003 Feb; 13(3):499-502. PubMed ID: 12565959
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship of ortho- and meta-phenol based LFA-1 ICAM inhibitors.
Lin EY; Guckian KM; Silvian L; Chin D; Boriack-Sjodin PA; van Vlijmen H; Friedman JE; Scott DM
Bioorg Med Chem Lett; 2008 Oct; 18(19):5245-8. PubMed ID: 18783948
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of a series of meta aniline-based LFA-1 ICAM inhibitors.
Guckian KM; Lin EY; Silvian L; Friedman JE; Chin D; Scott DM
Bioorg Med Chem Lett; 2008 Oct; 18(19):5249-51. PubMed ID: 18778938
[TBL] [Abstract][Full Text] [Related]
4. 1,4-Diazepane-2,5-diones as novel inhibitors of LFA-1.
Wattanasin S; Kallen J; Myers S; Guo Q; Sabio M; Ehrhardt C; Albert R; Hommel U; Weckbecker G; Welzenbach K; Weitz-Schmidt G
Bioorg Med Chem Lett; 2005 Feb; 15(4):1217-20. PubMed ID: 15686945
[TBL] [Abstract][Full Text] [Related]
5. De novo design, synthesis, and in vitro activity of LFA-1 antagonists based on a bicyclic[5.5]hydantoin scaffold.
Potin D; Launay M; Nicolai E; Fabreguette M; Malabre P; Caussade F; Besse D; Skala S; Stetsko DK; Todderud G; Beno BR; Cheney DL; Chang CJ; Sheriff S; Hollenbaugh DL; Barrish JC; Iwanowicz EJ; Suchard SJ; Dhar TG
Bioorg Med Chem Lett; 2005 Feb; 15(4):1161-4. PubMed ID: 15686933
[TBL] [Abstract][Full Text] [Related]
6. N-Benzoyl amino acids as LFA-1/ICAM inhibitors 1: amino acid structure-activity relationship.
Burdick DJ; Paris K; Weese K; Stanley M; Beresini M; Clark K; McDowell RS; Marsters JC; Gadek TR
Bioorg Med Chem Lett; 2003 Mar; 13(6):1015-8. PubMed ID: 12643901
[TBL] [Abstract][Full Text] [Related]
7. N-Benzoyl amino acids as ICAM/LFA-1 inhibitors. Part 2: structure-activity relationship of the benzoyl moiety.
Burdick DJ; Marsters JC; Aliagas-Martin I; Stanley M; Beresini M; Clark K; McDowell RS; Gadek TR
Bioorg Med Chem Lett; 2004 May; 14(9):2055-9. PubMed ID: 15080978
[TBL] [Abstract][Full Text] [Related]
8. Discovery and SAR of diarylsulfide cyclopropylamide LFA-1/ICAM-1 interaction antagonists.
Link JT; Sorensen B; Liu G; Pei Z; Reilly EB; Leitza S; Okasinski G
Bioorg Med Chem Lett; 2001 Apr; 11(8):973-6. PubMed ID: 11327603
[TBL] [Abstract][Full Text] [Related]
9. Amino-substituted heterocycles as isosteres of trans-cinnamides: design and synthesis of heterocyclic biaryl sulfides as potent antagonists of LFA-1/ICAM-1 binding.
Wang GT; Wang S; Gentles R; Sowin T; Leitza S; Reilly EB; von Geldern TW
Bioorg Med Chem Lett; 2005 Jan; 15(1):195-201. PubMed ID: 15582439
[TBL] [Abstract][Full Text] [Related]
10. Design of LFA-1 antagonists based on a 2,3-dihydro-1H-pyrrolizin-5(7aH)-one scaffold.
Dodd DS; Sheriff S; Chang CJ; Stetsko DK; Phillips LM; Zhang Y; Launay M; Potin D; Vaccaro W; Poss MA; McKinnon M; Barrish JC; Suchard SJ; Murali Dhar TG
Bioorg Med Chem Lett; 2007 Apr; 17(7):1908-11. PubMed ID: 17291752
[TBL] [Abstract][Full Text] [Related]
11. Statin-derived 1,3-oxazinan-2-ones as submicromolar inhibitors of LFA-1/ICAM-1 interaction: stabilization of the metabolically labile vanillyl side chain.
Ullrich T; Baumann K; Welzenbach K; Schmutz S; Camenisch G; Meingassner JG; Weitz-Schmidt G
Bioorg Med Chem Lett; 2004 May; 14(10):2483-7. PubMed ID: 15109637
[TBL] [Abstract][Full Text] [Related]
12. Novel p-arylthio cinnamides as antagonists of leukocyte function-associated antigen-1/intracellular adhesion molecule-1 interaction. 2. Mechanism of inhibition and structure-based improvement of pharmaceutical properties.
Liu G; Huth JR; Olejniczak ET; Mendoza R; DeVries P; Leitza S; Reilly EB; Okasinski GF; Fesik SW; von Geldern TW
J Med Chem; 2001 Apr; 44(8):1202-10. PubMed ID: 11312920
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and functional evaluation of leukocyte function associated antigen-1 antagonists in early and late stages of cancer development.
San Sebastián E; Zimmerman T; Zubia A; Vara Y; Martin E; Sirockin F; Dejaegere A; Stote RH; Lopez X; Pantoja-Uceda D; Valcárcel M; Mendoza L; Vidal-Vanaclocha F; Cossío FP; Blanco FJ
J Med Chem; 2013 Feb; 56(3):735-47. PubMed ID: 23339734
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of a human monoclonal antagonistic antibody AL-57 that preferentially binds the high-affinity form of lymphocyte function-associated antigen-1.
Huang L; Shimaoka M; Rondon IJ; Roy I; Chang Q; Po M; Dransfield DT; Ladner RC; Edge AS; Salas A; Wood CR; Springer TA; Cohen EH
J Leukoc Biol; 2006 Oct; 80(4):905-14. PubMed ID: 16888085
[TBL] [Abstract][Full Text] [Related]
15. Discovery of tetrahydroisoquinoline (THIQ) derivatives as potent and orally bioavailable LFA-1/ICAM-1 antagonists.
Zhong M; Shen W; Barr KJ; Arbitrario JP; Arkin MR; Bui M; Chen T; Cunningham BC; Evanchik MJ; Hanan EJ; Hoch U; Huen K; Hyde J; Kumer JL; Lac T; Lawrence CE; Martell JR; Oslob JD; Paulvannan K; Prabhu S; Silverman JA; Wright J; Yu CH; Zhu J; Flanagan WM
Bioorg Med Chem Lett; 2010 Sep; 20(17):5269-73. PubMed ID: 20655213
[TBL] [Abstract][Full Text] [Related]
16. Adxanthromycins A and B, new inhibitors of ICAM-1/LFA-1 mediated cell adhesion molecule from Streptomyces sp. NA-148. I. Taxonomy, production, isolation and biological activities.
Nakano T; Koiwa T; Takahashi S; Nakagawa A
J Antibiot (Tokyo); 2000 Jan; 53(1):12-8. PubMed ID: 10724002
[TBL] [Abstract][Full Text] [Related]
17. Virtual screening leads to the discovery of an effective antagonist of lymphocyte function-associated antigen-1.
Shoda M; Harada T; Yano K; Stahura FL; Himeno T; Shiojiri S; Kogami Y; Kouji H; Bajorath J
ChemMedChem; 2007 Apr; 2(4):515-21. PubMed ID: 17340656
[TBL] [Abstract][Full Text] [Related]
18. Characterization of molecular interactions between intercellular adhesion molecule-1 and leukocyte function- associated antigen-1.
Woska JR; Morelock MM; Jeanfavre DD; Bormann BJ
J Immunol; 1996 Jun; 156(12):4680-5. PubMed ID: 8648112
[TBL] [Abstract][Full Text] [Related]
19. Structure of an allosteric inhibitor of LFA-1 bound to the I-domain studied by crystallography, NMR, and calorimetry.
Crump MP; Ceska TA; Spyracopoulos L; Henry A; Archibald SC; Alexander R; Taylor RJ; Findlow SC; O'Connell J; Robinson MK; Shock A
Biochemistry; 2004 Mar; 43(9):2394-404. PubMed ID: 14992576
[TBL] [Abstract][Full Text] [Related]
20. Binding site elucidation of hydantoin-based antagonists of LFA-1 using multidisciplinary technologies: evidence for the allosteric inhibition of a protein--protein interaction.
Last-Barney K; Davidson W; Cardozo M; Frye LL; Grygon CA; Hopkins JL; Jeanfavre DD; Pav S; Qian C; Stevenson JM; Tong L; Zindell R; Kelly TA
J Am Chem Soc; 2001 Jun; 123(24):5643-50. PubMed ID: 11403595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
